Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,040.47 -951.03 (-1.49%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
Fortress Biotech, Inc. (FBIOP)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.53 |
| 52-week change 3 | -24.69% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 18.91 |
| 52-week low 3 | 6.40 |
| 50-day moving average 3 | 15.88 |
| 200-day moving average 3 | 13.61 |
Share statistics
| Avg vol (3-month) 3 | 12.48k |
| Avg vol (10-day) 3 | 17.54k |
| Shares outstanding 5 | 56.68M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 14.26M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 0.00% |
| Shares short (15 Apr 2024) 4 | 4.83k |
| Short ratio (15 Apr 2024) 4 | 0.74 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | N/A |
| Shares short (prior month 15 Mar 2024) 4 | 5.57k |
Dividends & splits
| Forward annual dividend rate 4 | 2.34 |
| Forward annual dividend yield 4 | 16.96% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 12.69 |
| Payout ratio 4 | N/A |
| Dividend date 3 | 30 Apr 2024 |
| Ex-dividend date 4 | 12 Apr 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -71.75% |
| Operating margin (ttm) | -1.58% |
Management effectiveness
| Return on assets (ttm) | -37.68% |
| Return on equity (ttm) | -597.36% |
Income statement
| Revenue (ttm) | 84.51M |
| Revenue per share (ttm) | 10.42 |
| Quarterly revenue growth (yoy) | 137.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -133.2M |
| Net income avi to common (ttm) | -68.67M |
| Diluted EPS (ttm) | -0.86 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 80.93M |
| Total cash per share (mrq) | 4.21 |
| Total debt (mrq) | 88.59M |
| Total debt/equity (mrq) | 5,582.36% |
| Current ratio (mrq) | 1.38 |
| Book value per share (mrq) | 1.49 |
Cash flow statement
| Operating cash flow (ttm) | -128.22M |
| Levered free cash flow (ttm) | -100.12M |
© 2024 Yahoo. All rights reserved.